Form 4 for PVLA PALVELLA THERAPEUTICS, INC.
Accepted 2025-11-21 00:00:00 ET · period of report 2025-11-19 · accession 0001104659-25-115017 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-11-21 | 2025-11-19 | PVLA | Goin Kathleen | COO | S - Sale+OE | $86.23 | -4,302 | 2,802 | -61% | -$371.0K |
| DM | 2025-11-21 | 2025-11-19 | PVLA | Goin Kathleen | COO | M - OptEx | $8.11 | +4,302 | 4,302 | New | +$34.9K |
| DM | 2025-11-21 | 2025-11-19 | PVLA | Goin Kathleen | COO | M - OptEx | $0.00 | -4,302 | 23.7K | -15% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-19 | S | D | 2,802 | $86.51 | 0 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $86.485 to $86.97. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above. |
| 2 | Common | Common Stock | 2025-11-19 | S | D | 1,500 | $85.72 | 2,802 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $85.475 to $86.08. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above. |
| 3 | Common | Common Stock | 2025-11-19 | M | A | 2,154 | $7.14 | 2,154 | D | — | — | |
| 4 | Common | Common Stock | 2025-11-19 | M | A | 2,148 | $9.08 | 4,302 | D | — | — | |
| 5 | Derivative | Stock Option (Right to Buy) | 2025-11-19 | M | D | 2,148 | $0.00 | 23,628 | D | $9.08 · — to 2030-10-14 | 2,148 Common Stock | (F4) The stock option is fully vested. |
| 6 | Derivative | Stock Option (Right to Buy) | 2025-11-19 | M | D | 2,154 | $0.00 | 23,705 | D | $7.14 · — to 2029-10-29 | 2,154 Common Stock | (F4) The stock option is fully vested. |